首页> 外文OA文献 >Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties.
【2h】

Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties.

机译:从重组毕赤酵母中纯化乙型肝炎表面抗原病毒样颗粒并对其免疫原性进行体内分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Following earlier studies on high-level intracellular production of hepatitis B surface antigen (HBsAg) using recombinant Pichia pastoris, we present here in detail an enhanced method for the purification of recombinant HBsAg virus-like particles (VLPs). We have screened various detergents for their ability to promote the solubilization of recombinant intracellular HBsAg. In addition, we have analyzed the effect of cell disruption and extraction regarding their impact on the release of HBsAg. Our results show that introduction of the mild nonionic detergent Tween 20 in the initial process of cell lysis at ∼600bars by high pressure homogenization leads to the best results. The subsequent purification steps involved polyethylene glycol precipitation of host cell contaminants, hydrophobic adsorption of HBsAg to colloidal silica followed by ion-exchange chromatography and either isopycnic density ultracentrifugation or size exclusion chromatography for the recovery of the VLPs. After final KSCN treatment and dialysis, a total yield of ∼3% with a purity of >99% was reached. The pure protein was characterized by electron microscopy, showing the presence of uniform VLPs which are the pre-requisite for immunogenicity. The intramuscular co-administration of HBsAg VLPs, with either alum or a PEGylated-derivative of the toll-like receptor 2/6 agonist MALP-2, to mice resulted in the elicitation of significantly higher HBsAg-specific IgG titers as well as a stronger cellular immune response compared to mice vaccinated with a gold standard vaccine (Engerix™). These results show that P. pastoris derived HBsAg VLPs exhibit a high potential as a superior biosimilar vaccine against hepatitis B.
机译:在使用重组毕赤酵母对B细胞表面抗原(HBsAg)进行高水平细胞内生产的早期研究之后,我们在这里详细介绍了一种纯化重组HBsAg病毒样颗粒(VLP)的增强方法。我们筛选了各种去污剂促进重组细胞内HBsAg增溶的能力。此外,我们已经分析了细胞分裂和提取对其对HBsAg释放的影响。我们的结果表明,在通过高压均质法在约600bars的细胞裂解初始过程中引入温和的非离子型去污剂Tween 20可获得最佳结果。随后的纯化步骤包括聚乙二醇沉淀宿主细胞污染物,疏水性吸附HBsAg到胶体二氧化硅,随后进行离子交换色谱,等密度密度超速离心或尺寸排阻色谱以回收VLP。经过最终的KSCN处理和透析后,总产率约为3%,纯度> 99%。通过电子显微镜对纯蛋白进行表征,表明存在均一的VLP,这是免疫原性的前提。肌内注射HBsAg VLPs与明矾或Toll样受体2/6激动剂MALP-2的聚乙二醇化衍生物共同导致小鼠产生明显更高的HBsAg特异性IgG滴度以及更强的与接种金标准疫苗(Engerix™)的小鼠相比,细胞免疫应答更高。这些结果表明,巴斯德毕赤酵母衍生的HBsAg VLP作为抗乙肝的优良生物仿制疫苗具有很高的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号